As a BRD4 inhibitor, JQ1 is firstly discovered as an anti-tumor compounds (12, 13), but growing evidences indicate that JQ1 becomes a recognized anti-inflammatory tool to study the functions of BRD4 particularly in inflammation-related diseases, such as cardiac hypertrophy and periodontitis (14–16). Here, BRD4 is linked to neoplasm.